Liver disease growth study pulled before it started
NCT ID NCT01314508
First seen Apr 17, 2026 · Last updated May 14, 2026 · Updated 5 times
Summary
This study planned to give a growth factor drug (Increlex) to children aged 4-18 with chronic liver disease and short stature to see if it would help them grow. The goal was to improve height, body mass index, and quality of life. However, the study was withdrawn before any participants were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.